<DOC>
	<DOCNO>NCT00339469</DOCNO>
	<brief_summary>This study , sponsor National Cancer Institute Penn State University , examine diet high legume ( dried bean ) influence risk factor colon cancer polyp . Many scientist believe colon rectal cancer develop polyp ( tumor line large bowel ) . This study test whether high-legume diet reduce level certain factor ( blood insulin , blood glucose , marker inflammation C-reactive protein ) elevate level know increase risk colorectal polyp colon cancer . Healthy men 35 75 year age may eligible study , conduct Penn State University University Park , Pennsylvania . Candidates screen blood test measurement height , weight , blood pressure . All candidate must colonoscopy within 2 year enter study . They may may adenomas may may insulin-resistant . Candidates must cancer , heart disease , kidney disease , diabetes , serious medical condition , must history colorectal cancer , polyp removal , bowel surgery , polyposis syndrome , inflammatory bowel disease . Participants undergo follow test procedure : - Caloric requirement testing : The subject 's rest metabolic rate measure fast early morning rest determine daily calorie requirement begin study diet . A special clear plastic hood place subject 's head breathing measure . He communicate technician time 30-minute test . - Study diet : Subjects follow two require 4-week diet 3-week break , follow optional third 4-week diet . Subjects eat healthy American diet require 4-week diet period ; 1-1/2 cup cook legume , pinto , bake , navy bean add one two required diet . For third ( optional ) diet period , subject give 1-1/2 cup legume , allow lose weight . Participants give package food consume three diet period . They may add five caffeine-containing beverage per day two alcoholic drink per week . They must eat food give food give . Subjects expect maintain constant body weight two 4-week require diet , caloric intake may increase decrease needed maintain screen weight . - Weight measurement : Subjects weigh regularly clinic . - Blood sample : Subjects blood sample draw mid-point two require 4-week diet begin end three 4-week diet . - Urine stool sample : Urine stool sample collect begin end two require 4-week diet .</brief_summary>
	<brief_title>Effect High-Legume Diet Colorectal Cancer Risk</brief_title>
	<detailed_description>Clinical , epidemiological , molecular study provide compel evidence colorectal cancer arise adenomas . The epidemiology adenomas closely resembles colorectal cancer , prevention adenoma likely prevent colorectal cancer . Insulin resistance type 2 diabetes emerge significant risk factor colorectal ( CRC ) cancer adenoma . Insulin resistance define impaired biological response action insulin . It characterize compensatory hyperinsulinemia associate increase risk Type 2 diabetes . C-peptide , marker insulin production , elevate IR also risk factor CRC . Both insulin resistance colorectal cancer increasingly recognize chronic , low-level , inflammatory state . C-reactive protein ( CRP ) , acute phase protein sensitive marker sub-clinical inflammation , risk factor IR CRC . Analysis Polyp Prevention Trial ( PPT ) , multi-center , randomize trial 1905 participant colorectal adenoma , show legume consumption significantly associate reduction adenoma recurrence advance adenoma recurrence . Legumes rich source dietary fiber anti-inflammatory , anti-cancer phytochemical . We evaluate effect legume enrich , low glycemic index , high fermentable fiber diet , CRP , ( measure inflammation ) C-peptide ( measure insulin resistance ) participant four possible combination risk factor insulin resistance history adenomatous polyp . In randomized crossover design control feeding study participant consume experimental diet control diet four week two week washout period diet . 65 male participant recruit randomized four group . A secondary objective ass whether endpoint change IR status history adenoma . In addition , potential fecal marker CRC risk measure assess change gastrointestinal inflammation , include mRNA exfoliate fecal colonocytes . To knowledge first control feeding study : 1. examine effect legumes low GI diet marker inflammation ; 2. compare effect dietary intervention patient history colon adenoma without IR ; 3. measure effect dietary change human intestinal gene expression profile use exfoliated colonocytes .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Colonic Neoplasms</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>INCLUSION CRITERIA 1 . Subjects 3575 year old . 2 . Subjects male . 3 . Subjects BMI 25.034.9 kg/m ( 2 ) Group 1 ( adenoma , IR ) 4 . Subjects colonoscopy within last two year 5 . Subjects one histologically confirm adenomas remove colon colonoscopy last two year , cecum visualize , polyp remove , bowel adequately prepare . 6 . Subjects either adenoma previous colonoscopy multiple adenoma colonoscopy . 7 . Subjects one previous adenoma colon . Rectal adenoma exclude . ( If person rectal adenomas 1 colon numerous rectal adenoma exclude study , since epidemiology rectal colon adenoma differ ) 8 . Subjects insulin resistance determine Homeostasis Assessment Model ( HOMAIR ) , mathematical model allow value insulin sensitivity betacell function ( expressed percent normal ) obtain simultaneous fast plasma glucose fasting insulin . HOMAIRA calculate fast serum insulin ( FI uU/mL ) ; fast glucose ( FG mmol/L ) / 22.5 HOMAIR = FIxFG/22.5 ( 188 ) . Values great equal 2.61 consider insulin resistant Group 2 ( adenoma , non IR ) 9 . Subjects colonoscopy within last two year . 10 . Subjects one histologically confirm colorectal adenoma remove colonoscopy last two year cecum visualize , polyp remove , bowel adequately prepare . 11 . Subjects either adenoma previous colonoscopy multiple adenoma colonoscopy . 12 . Subjects 1 adenoma colon ( vs rectum ) . 13 . Subjects insulin resistance determine HOMAIR . Group 3 ( adenoma , IR ) 14 . Subjects ( control ) colonoscopy within last two year histologically confirm colorectal adenoma colonoscopy , cecum visualize bowel adequately prepare . 15 . Subjects previous adenoma . 16 . Subjects insulin resistant determine HOMAIR . Group 4 ( adenoma , non IR ) 17 . Subjects ( control ) colonoscopy within last two year histologically confirm colorectal adenoma colonoscopy , cecum visualize bowel adequately prepare . 18 . Subjects previous adenoma . 19 . Subjects insulin resistance determine HOMAIR . EXCLUSION CRITERIA All Subjects 1 . A serious medical condition cancer , heart disease , kidney disease , diabetes serious medical condition . 2 . A history colorectal cancer , surgical resection adenoma , bowel resection , polyposis syndrome , inflammatory bowel disease . 3 . Smoked regularly past year . 4 . Have medical condition dietary restriction practice would substantially limit compliance dietary protocol . 5 . Planning change diet , exercise health behavior next 6 month . 6 . Taking medication may alter inflammation marker , insulin , glucose , lipid . Potential participant regularly use follow preparation : Antibiotics Nonsteroidal antiinflammatory drug ( aspirin nonaspirin NSAIDS like inbuprofen , naproxen , indomethacin , piroxicam , COX2specific inhibitor drug celecoxib , etodolac , meloxicam ) Glucocorticoids steroids Oral glucose preparation ( e.g . Actos , Amaryl , Avandia , DiaBeta , Diabinese , Dymelor , Glucophage ( XR ) , Glucotrol ( XL ) , Glucovance , Glynase Pres Tab , Glyset , Micronase , Orinase , Prandin , Precose , Starlix , Tolinase ) Insulin injection Statins ( e.g . atorvastatin , fluvastatin , lovastatin , pravastatin , rosuvastatin , simvastatin ) Bile Acid Resins ( e.g . cholestyramine , colestipol , colesevelam ) Nicotinic Acid ( Niacin ) Fibrates ( e.g . clofibrate , fenofibrate , gemfibrozil ) Combination Lipid Lowering Drugs ( e.g . Crestor ) Participants ask use supplement ( include herbal alternative therapy ) regular multivitamin/mineral participating study . While ask subject stop use OTC medication study , recognize may occasional use OTC analgesic course study . At least circumstance permit use OTC analgesic , otherwise list exclusion criterion . At scheduled blood draw , ask subject report use OTC medication past week . Participants also ask limit use alcohol study less equal 2 drinks/week .</criteria>
	<gender>Male</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 14, 2017</verification_date>
	<keyword>Prevention</keyword>
	<keyword>Colorectal Neoplasms</keyword>
	<keyword>Insulin Resistance</keyword>
	<keyword>Inflammation Obesity</keyword>
	<keyword>Adenoma</keyword>
</DOC>